Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chang Ji An capsule for diarrhea-predominant IBS (liver-qi attacking spleen pattern)
CTR20180991Phase 2Completed
- Sponsor
- First Affiliated Hospital of Guangzhou University of Chinese Medicine
- Start
- Aug 2018
- Countries
- 1
01
Overview
A Phase 2 trial of Changji'an Capsule in Irritable bowel syndrome with diarrhea (IBS-D), sponsored by First Affiliated Hospital of Guangzhou University of Chinese Medicine. Started Aug 2018; status: completed.
02
Drugs
Changji'an Capsule
03
Conditions
Irritable bowel syndrome with diarrhea (IBS-D)
Beyond the preview
Go deeper on CTR20180991.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20180991.